HFE hemochromatosis and hepatic sarcoid

American Journal of the Medical Sciences

Volumn 337, Issue 5, 2009, Pages 386-390

  Barton, James C ^a,b,d   McGuire, Brendan M ^b   Acton, Ronald T ^c  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d NONE   (United States)

Author keywords

Granuloma; Haplo Type; Human leukocyte antigen; Iron overload; Liver

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FERRITIN; HFE PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; IRON; METFORMIN; NADOLOL; PIOGLITAZONE; SPIRONOLACTONE;

ABDOMINAL DISCOMFORT; ABDOMINAL SWELLING; ARTICLE; BODY MASS; CASE REPORT; CAUCASIAN; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; CHRONIC FATIGUE SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; FEMALE; GAMMOPATHY; HAPLOTYPE; HEMOCHROMATOSIS; HEPATOMEGALY; HIATUS HERNIA; HLA TYPING; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOELECTROPHORESIS; IRON DEPLETION; LEG EDEMA; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER GRANULOMA; LYMPHADENOPATHY; MALE; MUTATIONAL ANALYSIS; NEPHROLITHIASIS; NONALCOHOLIC FATTY LIVER; PHLEBOTOMUS; PORTAL HYPERTENSION; SARCOIDOSIS; SPLENOMEGALY; STOMACH VARICES; VASCULARIZATION; WELLBEING; ADULT; FAMILY HEALTH; FIBROSIS; GENETICS; GENOTYPE; GRANULOMA; HETEROZYGOTE; METABOLISM; MIDDLE AGED;

ADULT; FAMILY HEALTH; FEMALE; FIBROSIS; GENOTYPE; GRANULOMA; HEMOCHROMATOSIS; HEPATOCYTES; HETEROZYGOTE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; SARCOIDOSIS;

EID: 67649112083     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318191ed17     Document Type: Article

References (40)

1. Fcder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
2. Barton JC, Acton RT. HLA-A and-B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama. BMC Med Genet 2002;3:9.
3. Beutler E, Felitti V, Gelbart T, et al. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000;133:329-37.
4. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78.
5. Acton RT, Barton JC, Snively BM, et al. Geographic and racial/ ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis 2006; 16: 815-21.
6. Barton JC, Wiener HW, Acton RT, et al. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis 2005;34:38-47.
7. Barton JC, Acton RT, Dawkins FW, et al. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochroma tosis and Iron Overload Screening Study. Genet Test 2005;9:231-41.
8. Iannuzzi MC. Advances in the genetics of sarcoidosis. Proc Am Thorac Soc 2007;4:457-60.
9. Devaney K, Goodman ZD, Epstein MS, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993;17: 1272-80.
10. Wong VS, Adab N, Youngs GR, et al. Hepatic sarcoidosis complicated by hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1999; 11:353-5.
11. Bilir M, Mert A, Ozaras R, et al. Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients. J Clin Gastroenterol 2000;31: 337-8.
12. Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol 2006;5:251-6.
13. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41.
14. Schurmann M, Bein G, Kirsten D, et al. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis. Respir Med 1998;92:649-52.
15. Schurmann M, Lympany PA, Reichel P, et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000;162:861-4.
16. Schurmann M, Reichel P, Miiller-Myhsok B, et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001;164:840-6.
17. Brennan NJ, Crean P, Long JP, et al. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984;39:14-18.
18. McGrath DS, Daniil Z, Foley P, et al. Epidemiology of familial sarcoidosis in the UK. Thorax 2000;55:751-4.
19. Perng RP, Chou KT, Chu H, et al. Familial sarcoidosis in Taiwan. J Formos Med Assoc 2007;106:499-503.
20. Harrington D, Major M, Rybicki B, et al. Familial analysis of 91 families. Sarcoidosis 1994;11:240-3.
21. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962;84:53-64.
22. Barton JC, Shih WW, Sawada-Hirai R, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997;23:135-45.
23. Ayensa Dean C, Agud Aparicio J, Sanchez Nanclares M. [Sarcoidosis and hemochromatosis]. Rev Clin Esp 1987;181:171.
24. Riia-Figueroa I, de Vega T, Echevarria S, et al. [Sarcoidosis and hemochromatosis]. Med Clin (Bare) 1992;98:315-6.
25. Wallace DF, Clark RM, Harley HA, et al. Autosomal dominant iron overload due to a novel mutation of ferroportinl associated with parenchymal iron loading and cirrhosis. J Hepatol 2004;40:710-13.
26. Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006;18:721-6.
27. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37:357-64.
28. Rybicki BA, Walewski JL, Maliarik MJ, et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005;77:491-9.
29. Engle RL Jr. The association of iron-containing crystals with Schaumann bodies in the giant cells of granulomas of sarcoid type. Am J Pathol 1951;27:1023-35.
30. Liebling ME, Bell NH, Stengle JM. Studies of the production, volume and destruction of erythrocytes in patients with sarcoidosis. Am Rev Respir Dis 1961;84(Pt 2):32-7.
31. Dubaniewicz A, Jamieson SE, Dubaniewicz-Wybieralska M, et al. Association between SLC11A1 (formerly NRAMPJ) and the risk of sarcoidosis in Poland. Eur J Hum Genet 2005;13:829-34.
32. Barton CH, Biggs TE, Baker ST, et al. Nrampl: a link between intracellular iron transport and innate resistance to intracellular pathogens. J Leukoc Biol 1999;66:757-62.
33. Biggs TE, Baker ST, Botham MS, et al. Nrampl modulates iron homoeostasis in vivo and in vitro: evidence for a role in cellular iron release involving de-acidification of intracellular vesicles. Eur J Immunol 2001;31:2060-70.
34. Montosi G, Paglia P, Garuti C, et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 2000;96:1125-29.
35. Adams PC, Barton JC. Haemochromatosis. Lancet 2007;370:1855-60.
36. Powell EE, Ali A, Clouston AD, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 2005;129:1937-43.
37. Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130:953-62.
38. Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 1998;129:932-9.
39. De Gobbi M, Roetto A, Piperno A, et al. Natural history of juvenile haemochromatosis. Br J Haematol 2002;117:973-9.
40. Sham RL, Phatak PD, West C, et al. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis 2005;34:157-61.